首页> 外文期刊>Clinical oncology >Treatment Receipt and Outcomes among Lung Cancer Patients with Depression
【24h】

Treatment Receipt and Outcomes among Lung Cancer Patients with Depression

机译:患有抑郁症的肺癌患者的治疗收支和结果

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: Among lung cancer patients, depression has been associated with increased mortality, although the mechanisms are unknown. We evaluated the association of depression with mortality and receipt of cancer therapies among depressed veterans with lung cancer. Materials and methods: A retrospective, cohort study of lung cancer patients in the Veterans Affairs-Northwest Health Network from 1995 to 2010. Depression was defined by ICD-9 coding within 24 months before lung cancer diagnosis. Multivariable Cox proportional analysis and logistic regression were used. Results: In total, 3869 lung cancer patients were evaluated; 14% had a diagnosis of depression. A diagnosis of depression was associated with increased mortality among all stage lung cancer patients (hazard ratio=1.14, 95% confidence interval: 1.03-1.27, P=0.01). Among early-stage (I and II) non-small cell lung cancer (NSCLC) patients, the hazard ratio was 1.37 (95% confidence interval: 1.12-1.68, P=0.003). There was no association of depression diagnosis with surgery (odds ratio=0.83, 95% confidence interval: 0.56-1.22, P=0.34) among early-stage NSCLC patients. A depression diagnosis was not associated with mortality (hazard ratio=1.02, 95% confidence interval: 0.89-1.16, P=0.78) or chemotherapy (odds ratio=1.07, 95% confidence interval: 0.83-1.39, P=0.59) or radiation (odds ratio=1.04, 95% confidence interval: 0.81-1.34, P=0.75) receipt among advanced-stage (III and IV) NSCLC patients. Increased utilisation of health services for depression was associated with increased mortality among depressed patients. Conclusions: Depression is associated with increased mortality in lung cancer patients and this association is higher among those with increased measures of depression care utilisation. Differences in lung cancer treatment receipt are probably not responsible for the observed mortality differences between depressed and non-depressed patients. Clinicians should recognise the significant effect of depression on lung cancer survival.
机译:目的:在肺癌患者中,抑郁症与死亡率增加有关,尽管其机制尚不清楚。我们评估了抑郁症与肺癌的退伍军人之间的关系与抑郁与死亡率和癌症治疗的接受。材料和方法:1995年至2010年在退伍军人事务西北卫生网络中对肺癌患者进行的一项回顾性队列研究。抑郁症是在肺癌诊断前24个月内通过ICD-9编码定义的。使用多变量Cox比例分析和逻辑回归。结果:总共评估了3869名肺癌患者; 14%的人患有抑郁症。在所有阶段的肺癌患者中,抑郁的诊断与死亡率增加相关(危险比= 1.14,95%置信区间:1.03-1.27,P = 0.01)。在早期(I和II)非小细胞肺癌(NSCLC)患者中,危险比为1.37(95%置信区间:1.12-1.68,P = 0.003)。早期NSCLC患者中抑郁症诊断与手术没有相关性(几率= 0.83,95%置信区间:0.56-1.22,P = 0.34)。抑郁症的诊断与死亡率(危险比= 1.02,95%置信区间:0.89-1.16,P = 0.78)或化学疗法(优势比= 1.07,95%置信区间:0.83-1.39,P = 0.59)或放射线无关。晚期(III和IV)NSCLC患者中的接受率(比值= 1.04,95%置信区间:0.81-1.34,P = 0.75)。抑郁症保健服务利用率的提高与抑郁症患者的死亡率增加相关。结论:抑郁症与肺癌患者死亡率增加相关,而在抑郁症治疗利用措施增加的患者中,这种关联性更高。肺癌治疗接受的差异可能与抑郁症患者和非抑郁症患者之间观察到的死亡率差异无关。临床医生应认识到抑郁症对肺癌生存的重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号